Replies to post #15487 on Biotech Values

[DewDiligence]

LOL re ABT’s statement on Xinlay:

http://biz.yahoo.com/prnews/050913/cgtu047.html?.v=26

>>
"The company is encouraged by committee member statements regarding the activity of Xinlay and the value of continuing development of the drug. We await FDA's decision on Xinlay."
<<

Lame.